Tea intake, COMT genotype, and breast cancer in Asian-American women

• Published in: Cancer research (Chicago, Ill.) Ill.), 2003-11, Vol.63 (21), p.7526-7529
• Main Authors: WU, Anna H, TSENG, Chiu-Chen, VAN DEN BERG, David, YU, Mimi C
• Format: Article
• Language: English
• Subjects: Adult; Aged; Alleles; Antineoplastic agents; Asian Americans; Biological and medical sciences; Breast Neoplasms - enzymology; Breast Neoplasms - epidemiology; Breast Neoplasms - genetics; Breast Neoplasms - prevention & control; Catechol O-Methyltransferase - genetics; China - ethnology; Female; Genotype; Humans; Japan - ethnology; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Philippines - ethnology; Tea; Tumors; United States - epidemiology
• ISSN: 0008-5472; 1538-7445

There is substantial in vitro and in vivo evidence implicating tea polyphenols as chemopreventive agents against various cancers. In a case-control study conducted among Asian-American women in Los Angeles County, we reported a significant inverse relationship between intake of green tea and risk of breast cancer (A. H. Wu et al., Int. J. Cancer, 106: 574-579, 2003). Because catechol-containing tea polyphenols are very rapidly O-methylated by human catechol-O-methyltransferase (COMT), we are interested in determining whether the association between tea intake and breast cancer differed in women according to COMT genotype. We examined the interrelationships between tea intake, COMT genotype, and breast cancer risk in 589 incident cases and 563 population-based controls from a population-based case-control study of breast cancer in Chinese-, Japanese-, and Filipino-American women in Los Angeles County. Risk of breast cancer was influenced significantly by intake of tea, particularly green tea intake. However, the inverse association between tea intake and breast cancer risk was observed only among individuals who possessed at least one low-activity COMT allele. Among women who carried at least one low activity COMT allele, tea drinkers showed a significantly reduced risk of breast cancer (adjusted odds ratio, 0.48; 95% confidence interval, 0.29-0.77) compared with nontea drinkers after adjustment for relevant demographic, menstrual, reproductive, and dietary factors. This risk reduction was observed in relation to both green tea and black tea intake. In contrast, risk of breast cancer did not differ between tea drinkers and nontea drinkers among those who were homozygous for the high activity COMT allele (adjusted odds ratio, 1.02; 95% confidence interval, 0.66-1.60). In conclusion, tea catechins appeared to reduce breast cancer risk in this study of Asian-American women. Reduction in risk was strongest among persons who had the low activity COMT alleles, suggesting these individuals were less efficient in eliminating tea catechins and may derive the most benefit from these compounds.